Genmab A/S (Nasdaq: GMAB) today announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which ...
Hair transplantation has emerged as one of the most rapidly advancing and widely practiced fields within aesthetic medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback